Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Celcuity Inc (CELC)

Celcuity Inc (CELC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Celcuity Inc 16305 36TH AVENUE NORTH SUITE 100 MINNEAPOLIS MN 55446 USA

www.celcuity.com Employees: 55 P: 763-392-0767

Description:

Celcuity Inc. is a cellular analysis company. It engaged in discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The company's proprietary CELx diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular activity driving a patient's cancer and the targeted therapy. Celcuity Inc. is based in Minneapolis, United States.

Key Statistics

Overview:

Market Capitalization, $K 552,858
Enterprise Value, $K 559,238
Shares Outstanding, K 37,030
Annual Sales, $ 0 K
Annual Net Income, $ -63,780 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -23,720 K
EBIT, $ -85,400 K
EBITDA, $ -85,020 K
60-Month Beta 0.76
% of Insider Shareholders 15.78%
% of Institutional Shareholders 63.33%
Float, K 31,187
% Float 84.22%
Short Volume Ratio 0.72

Growth:

1-Year Return 43.82%
3-Year Return -21.17%
5-Year Return 4.41%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -263.51%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.62 on 08/14/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -2.74
EPS Growth vs. Prev Qtr 3.12%
EPS Growth vs. Prev Year 6.06%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CELC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -60.83%
Return-on-Assets % -40.57%
Profit Margin % 0.00%
Debt/Equity 0.54
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.08
Book Value/Share 5.03
Interest Coverage -10.97
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar